<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>StockStream - MDGL News</title>
<link>https://stockstream.online/stocks/MDGL</link>
<description>Latest news and analysis for MDGL stock on StockStream.</description>
<language>en-us</language>
<lastBuildDate>Thu, 04 Jun 2026 03:48:39 +0000</lastBuildDate>
<atom:link href="https://stockstream.online/stocks/MDGL/feed.xml" rel="self" type="application/rss+xml"/>
<ttl>15</ttl>
<item><title>Advancements in Retinal Disease Therapeutics Put MDGL in the Spotlight</title><link>https://stockstream.online/news/mdgl-retinal-therapeutics-insight</link><description>Recent breakthroughs in retinal disease treatments position MDGL favorably in the biotech landscape. Explore key metrics and insights for informed investment.</description><pubDate>Wed, 25 Feb 2026 14:02:40 +0000</pubDate><guid isPermaLink="true">https://stockstream.online/news/mdgl-retinal-therapeutics-insight</guid><category>Healthcare</category></item>
<item><title>Wall Street Weighs In on MDGL After Kymera Therapeutics Breakthrough</title><link>https://stockstream.online/news/mdgl-kymera-therapeutics-breakthrough</link><description>Recent advancements by Kymera Therapeutics in targeted protein degradation raise important implications for MDGL investors. Here's the full picture.</description><pubDate>Tue, 24 Feb 2026 07:22:32 +0000</pubDate><guid isPermaLink="true">https://stockstream.online/news/mdgl-kymera-therapeutics-breakthrough</guid><category>Healthcare</category></item>
</channel>
</rss>